Novel anticancer agents from plant sources

Chinese Journal of Natural Medicines

Volumn 11, Issue 1, 2013, Pages 16-23

  Shah, Unnati ^a   Shah, Ripal ^b   Acharya, Sanjeev ^c   Acharya, Niyati ^c  

^a Pioneer Pharmacy Degree College   (India)

^b Sun Pharma Advanced Research Centre   (India)

^c NIRMA UNIVERSITY   (India)

Author keywords

Anticancer agents; Cancer; Medicinal plants

Indexed keywords

ANTINEOPLASTIC AGENT; BETA LAPACHONE; BETULIC ACID; CAMPTOTHECIN; CATHARANTHUS ROSEUS EXTRACT; CISPLATIN; COMBRETASTATIN; COMBRETASTATIN A4 PHOSPHATE; DOCETAXEL; ELLIPTINIUM; EPIPODOPHYLLOTOXIN; ETOPOSIDE; FLAVOPIRIDOL; HOMOHARRINGTONINE; IRINOTECAN; LAPACHOL; NAVELBINE; ORTATAXEL; PACLITAXEL; PACLITAXEL POLIGLUMEX; ROSCOVITINE; RUBITECAN; TAXUS BREVIFOLIA EXTRACT; TENIPOSIDE; TOPOTECAN; UNINDEXED DRUG; VINBLASTINE; VINCA ALKALOID; VINCRISTINE; VINFLUNINE;

ADVANCED CANCER; AGLAIA; ANTINEOPLASTIC ACTIVITY; APOCYNACEAE; ARTICLE; BREAST CANCER; BRONCHUS CANCER; CANCER COMBINATION CHEMOTHERAPY; CEPHALOTAXUS; COLON CANCER; COLORECTAL CANCER; COMBRETUM; CYTOTOXICITY; DRUG ISOLATION; HUMAN; JUJUBE; KAPOSI SARCOMA; LEUKEMIA; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; LYMPHOMA; MEDICINAL PLANT; MELANOMA CELL; NONHODGKIN LYMPHOMA; NONHUMAN; OVARY CANCER; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PODOPHYLLUM; RADISH; RHABDOMYOSARCOMA; SOLID TUMOR; TESTIS CANCER; TRANSITIONAL CELL CARCINOMA;

EID: 84872394296     PISSN: 20956975     EISSN: 18755364     Source Type: Journal    
DOI: 10.1016/S1875-5364(13)60002-3     Document Type: Article

References (42)

1. Mesquite de MC, Paula de JE, Pessoa C, et al. Cytotoxic activity of Brazilian Cerrado plants used in traditional medicine against cancer cell lines[J]. J Ethnopharmacol 2009, 123(2):439-445.
2. Fouche G, Cragg GM, Pillay P, et al. In vitro anticancer screening of South African plants[J]. J Ethnopharmacol 2008, 119(3):455-461.
3. Cragg GM, Newman DJ Plants as a source of anti-cancer agents[J]. J Ethnopharmacol 2005, 100(1-2):72-79.
4. Ames BN, Gold LS, Willett WC The causes and prevention of cancer[J]. Proc Natl Acad Sci USA 1995, 92(12):5258-5265.
5. Pandey G, Madhuri S Medicinal plants: better remedy for neoplasm[J]. Indian Drugs 2006, 43(11):869-874.
6. Rosangkima G, Prasad SB Antitumour activity of some plants from Meghalaya and Mizoram against murine ascites Dolton's lymphoma[J]. Indian J Exp Biol 2004, 42:981-988.
7. Madhuri S, Pandey G Some dietary agricultural plants with anticancer properties[J]. Plant Arch 2008, 8(1):13-16.
8. Sivalokanathan S, Ilayaraja M, Balasubramanium MP Efficacy of Terminalia arjuna (Roxb.) on N-nitrosodiethylamine induced hepatocellular carcinoma in rats[J]. Indian J Exp Biol 2005, 43:264-267.
9. Luduene RF Multiple form of tubulin: different gene products and covalent modification[J]. Int Rev Cytology 1998, 178(13):207.
10. Neoh CK Typhonium divaricatum (Rodent Tuber): a promising local plant in the fight against cancer[J]. Med J Malaysia 1992, 47(1):86-88.
11. Mehndiratta S, Kumar S, Kumar Meena A, et al. A review on lants a useful source of anti-cancer drugs[J]. J Pharm Res 2011, 4(1):264-271.
12. Wani Mc, Taylor Hl, Wall Me, et al. Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia[J]. J Am Chem Soc 1971, 93(13):2325-2327.
13. Canel C, Moraes RM, Dayan FE, et al. Molecules of interest: podophyllotoxin podophyllotoxin[J]. Phytochemistry 2000, 54(2):115-120.
14. Cirla A, Mann J Combrestatins: from natural product to drug discovery[J]. Nat Prod Rep 2003, 20:558-564.
15. Itokawa H, Wang X Homoharringtonine and related compounds. Anticancer Agents from Natural Products[M] 2005, 47-70. Brunner-Routledge Psychology Press, Taylor and Francis Group, Boca Raton, Florida. G.M. Cragg, D.G.I. Kingston, D. Newman (Eds.).
16. Peters B New cancer therapies for 2007-looking to the future[J]. Oncology Issues 2007, 34-39.
17. Da Rocha AB, Lopes RM, Schwartsmann G Natural products in anticancer therapy[J]. Curr Opin Pharmacol 2001, 1(4):364-369.
18. Westwell AD Novel Antitumour molecules[J]. Drug Discov Today 2003, 8(1):47-50.
19. Newcomb EW Flavopiridol: pleiotropic biological effects enhance its anticancer activity[J]. Anti Cancer Drugs 2004, 15(5):411-419.
20. Kinghorn AD The discovery of drugs from higher plants. The Discovery of Natural Products with Therapeutic Potential[M] 1994, 81-108. Butterworth-Heinemann, Boston, MA. V.P. Gullo (Ed.).
21. Newman DJ, Cragg GM, Snader KM Natural products as sources of new drugs over the period 1981-2002[J]. J Nat Prod 2003, 66(7):1022-1037.
22. Cragg GM, Newman DJ A tale of two targets: Topoisomerase I and tubulin The Wall and Wani contribution to cancer chemotherapy[J]. J Nat Prod 2004, 67:232-244.
23. Saklani A, Kutty SK Plant-derived compounds in clinical trials[J]. Drug Disc Today 2008, 13(3-4):161-171.
24. Butler MS Natural products to drugs: natural product derived compounds in clinical trials[J]. Nat Prod Rep 2005, 22(2):162-195.
25. Giovanella BC, Stehlin JS, Wall ME DNA topoisomerase I-targeted chemotherapy of human colon cancer in xenografts[J]. Science 1989, 246(Nov-24):1046-1048.
26. Giovanella BC, Stehlin JS, Hinz HR, et al. Preclinical evaluation of the anticancer activity and toxicity of 9-nitro-20(S)-camptothecin (Rubitecan)[J]. Int J Oncol 2002, 20:81-88.
27. Ulukan H, Swaan PW Camptothecins: a review of their chemotherapeutic potential[J]. Drugs 2002, 62(14):2039-2057.
28. Singer JW, Shaffer S, Baker B, et al. Paclitaxel poliglumex (XYOTAX; CT-2103): an intracellularly targeted taxane[J]. Anticancer Drugs 2005, 16:243-254.
29. Spigel DR, Greco FA What is the role of novel taxanes in non-small-cell lung cancer [J]. Clin Lung Cancer 2008, 9(3):S116-S121.
30. Jones RJ, Hawkins RE, Eatock MM, et al. A phase II open-label study of DHA-paclitaxel (Taxoprexin) by 2-h intravenous infusion in previously untreated patients with locally advanced or metastatic gastric or oesophageal adenocarcinoma[J]. Cancer Chemother Pharmacol 2008, 61(3):435-441.
31. Anonymous Vincristine liposomal-INEX: lipid-encapsulated vincristine, onco TCS, transmembrane carrier system-vincristine, vincacine, vincristine sulfate liposomes for injection[J]. Drugs in R & D 2004, 5(2):119-123.
32. Erickson HP Negatively stained vinblastine aggregates[J]. Ann N.Y Acad Sci 1975, 253(Jun-30):51-52.
33. Na GC, Timasheff SN In vitro vinblastine-induced tubulin paracrystals[J]. J Biol Chem 1982, 257(11):10387-10391.
34. Jordan MA, Margolis RL, Himes RH Identification of a distinct class of vinblastine binding sites on microtubules[J]. J Mol Biol 1986, 187(1):61-73.
35. Kanat O, Ender K, Fatih O, et al. Single-agent vinorelbine as third-line chemotherapy for refractory non-small cell lung cancer[J]. Turk J Cancer 2006, 36(3):133-138.
36. European medicines agency evaluation of medicines for human use[R]. CHMP Assessment Report for Javlor, 370293/2009.
37. Letourneau R, Ghassan K, Abou A, et al. Randomized Phase III study of exatecan and gemcitabine compared with gemcitabine alone in untreated advanced pancreatic pancer[J]. J Clin Oncol 2006, 24(27):4441-4447.
38. Georgaki S, Skopeliti M, Tsiatas M, et al. Phenoxodiol, an anticancer isoflavene, induces immunomodulatory effects in vitro andin vivo[J]. J Cell Mol Med 2009, 3(9):3929-3938.
39. Bradbury J From Chinese medicine to anticancer drug[J]. Drug Discov Today 2005, 10(17):1131-1132.
40. Quesada AR, Muñoz-Chápuli R, Medina MA Anti-angiogenic drugs: from bench to clinical trials[J]. Med Res 2006, 26:483-530.
41. Westwell AD Novel antitumour molecules[J]. Drug Discov Today 2003, 8(20):47-50.
42. Hamann MT, Otto CS, Scheuer PJ Kahalalides: bioactive peptides from a marine mollusk Elysia rufescens and its algal diet Bryopsis sp[J]. J Org Chem 1996, 61(19):6594-6600.